EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Immunosuppressive Therapy-Related Cardiovascular Risk Factors in Renal Transplantation: A Narrative Review

Chiara Paccagnella, Stefano Andreola, Alessia Gambaro, Giovanni Gambaro, Chiara Caletti

Cardiorenal Medicine · 2025

DOI: 10.1159/000542378 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiorenal Medicine, 2025. Verfasst von Chiara Paccagnella und 4 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Postgraduate School, Division of Nephrology and Dialysis, Department of Medicine, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Cardiovascular Diseases, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 206 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background: Kidney transplantation is the best treatment for patients with chronic renal failure, capable of improving life expectancy and the risk of death from all causes, which, however, remains higher than in the general population. The leading cause of death in transplant patients is cardiovascular events, burdened by a significant impact brought about by anti-rejection therapy. Experimental and clinical studies to date show that in kidney transplant recipients, traditional cardiovascular risk factors (hypertension, diabetes, dyslipidemia, obesity, tobacco, etc.) may be exacerbated or worsened by the dysmetabolic effects of immunosuppressive drugs, which may also result in additional risk factors such as proteinuria, anemia, and arterial stiffness. The aim of this review was to provide an in-depth evaluation of the effect of immunosuppressive treatments on cardiovascular risk factors. Summary: We have investigated and described the main cardiovascular risk factors related to immunosuppressive drugs. We searched for relevant scientific articles in medicine, transplant, cardiologic, and nephrological journals in major medical science libraries. Key Messages: Immunosuppressive drugs allow graft survival and successful bunking of the transplant; however, they are not without significant side effects and should always be prescribed weighing the risk/benefit ratio and the individual patient’s therapeutic needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsCardiovascular DiseasesGraft RejectionKidney Failure, ChronicHumansHeart Disease Risk FactorsRisk FactorsGraft Survival

Stichwörter der Autor:innen

Cardiovascular riskCyclosporineImmunosuppressive therapyKidney transplantationMammalian target of rapamycinSteroidsTacrolimus

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Nephrology Postgraduate School, Division of Nephrology and Dialysis, Department of Medicine, University of Verona, Verona, Italy.
  • Division of Nephrology and Dialysis, Department of Medicine, University of Verona, Verona, Italy.
  • Division of Cardiology, Department of Medicine, University of Verona, Verona, Italy.

Zitieren

APA

Paccagnella, C., Andreola, S., Gambaro, A., Gambaro, G., & Caletti, C. (2025). Immunosuppressive Therapy-Related Cardiovascular Risk Factors in Renal Transplantation: A Narrative Review. Cardiorenal Medicine. https://doi.org/10.1159/000542378

Vancouver

Paccagnella C, Andreola S, Gambaro A, Gambaro G, Caletti C. Immunosuppressive Therapy-Related Cardiovascular Risk Factors in Renal Transplantation: A Narrative Review. Cardiorenal Medicine. 2025. doi:10.1159/000542378

BibTeX
@article{Paccagnella2025,
  author = {Paccagnella, Chiara and Andreola, Stefano and Gambaro, Alessia and Gambaro, Giovanni and Caletti, Chiara},
  title = {Immunosuppressive Therapy-Related Cardiovascular Risk Factors in Renal Transplantation: A Narrative Review},
  journal = {Cardiorenal Medicine},
  year = {2025},
  doi = {10.1159/000542378}
}
Kostenlos starten →